ArticleBioengineered2022

Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway.

Jieke Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.